Associated Papers
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients.
Kwong A et al.
Cancers, 2024
Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients.
Kwong A et al.
Bmc Cancer, 2020
Select a paper to view details